Amazon Pharmacy medical chief Gupta is latest health exec to leave company

Amazon Pharmacy medical chief Gupta is latest health exec to leave company


Vin Gupta, Chief Medical Officer at Amazon Pharmacy, speaks during Amazon’s “Delivering the Future” event at the company’s BFI1 Fulfillment Center, Robotics Research and Development Hub in Sumner, Washington on October 18, 2023. 

Jason Redmond | Afp | Getty Images

Amazon has lost the chief medical officer of its pharmacy division after five years at the company.

Dr. Vin Gupta, who most recently served as the medical chief of Amazon Pharmacy, joined Amazon in 2020 as the company was in the early stages of a multi-year effort to build out a health-care business.

Gupta has joined Manatt, Phelps & Phillips, LLP, a professional services firm, as a managing director to lead a portfolio dedicated to health innovation, according to a release. Amazon didn’t immediately name a successor for Gupta, whose LinkedIn profile says he left last month.

“We are grateful to Dr. Gupta for all of his contributions to Amazon Health Services and wish him the best in his next endeavor,” an Amazon spokesperson told CNBC in a statement Wednesday.

Gupta said in an emailed statement that Manatt, like Amazon, “is deeply focused on scaled impact to address problems which matter to patients nationwide,” including care access and the use of artificial intelligence “at the point of need.”

For Amazon CEO Andy Jassy, Gupta’s exit marks another high-profile departure across the health businesses. Earlier this month, One Medical CEO Trent Green announced he would step down from leading the primary care chain in April, after less than two years in the role. Amazon acquired One Medical for $3.9 billion in 2023, five years after snapping up online pharmacy PillPack for about $750 million.

In addition to his role within the pharmacy business, Gupta held several other positions over the course of his five years at the company, including Covid response lead and chief medical officer of new products in Amazon’s devices and services unit.

Gupta joined Amazon months before it launched its pharmacy offering, a service that was born out PillPack deal in 2018. In his role as chief medical officer, Gupta helped roll out a prescription perk for U.S. Prime members called RxPass and expanded its program for medication delivery by drones.

Gupta was also involved with a moonshot incubator at Amazon called Grand Challenge, which launched under founder Jeff Bezos as a way to develop experimental businesses, including health-care initiatives.

Disclosure: Dr. Vin Gupta contributes to NBC News as a medical analyst.

WATCH: Amazon Pharmacy chief medical officer on expanded ‘RxPass’ access

Amazon's Vin Gupta on expanded 'RxPass' access



Source

Chinese tech giants enter the ‘agentic commerce’ race as AI reshapes super apps
Technology

Chinese tech giants enter the ‘agentic commerce’ race as AI reshapes super apps

NANJING, CHINA – NOVEMBER 25: Aerial view of Alibaba Jiangsu Headquarters at night on November 25, 2025 in Nanjing, Jiangsu Province of China. (Photo by Fang Dongxu/VCG via Getty Images) Vcg | Visual China Group | Getty Images China’s technology giants are entering a new phase of the artificial intelligence race called ‘agentic commerce,’ as […]

Read More
Deutsche Bank declares ‘the honeymoon is over for AI’ —‎ here’s why
Technology

Deutsche Bank declares ‘the honeymoon is over for AI’ —‎ here’s why

Central banks and investment firms have warned of a sharp economic correction if AI disappoints investors. Now, Deutsche Bank says 2026 will be the hardest year yet for the technology. “AI will survive,” Adrian Cox and Stefan Abrudan, analysts at the investment bank, wrote in a Jan. 20 note titled “The honeymoon is over.” But […]

Read More
Cramer says wild speculation has returned to the market — and here’s what investors must do
Technology

Cramer says wild speculation has returned to the market — and here’s what investors must do

A wave of speculative buying has crashed over the stock market to start the new year, prompting CNBC’s Jim Cramer to urge investors to take profits in stocks that have gone parabolic. “You haven’t made a profit unless you ring the register on some of your gains,” Cramer said Tuesday night on “Mad Money.” Those […]

Read More